XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities    
Net income $ 470,885,000 $ 781,408,000
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Provisions for credit losses 128,595,000 (156,090,000)
Income tax expense 151,652,000 256,699,000
Amortization of brokered deposit placement fee 6,575,000 8,194,000
Amortization of Secured Borrowing Facility upfront fee 1,218,000 1,486,000
Amortization of deferred loan origination costs and loan premium/(discounts), net 8,186,000 7,983,000
Net amortization of discount on investments 1,022,000 4,079,000
(Increase) reduction in tax indemnification receivable (221,000) 5,649,000
Depreciation of premises and equipment 8,489,000 7,545,000
Acquired intangible assets amortization expense 3,150,000 0
Stock-based compensation expense 20,296,000 17,568,000
Unrealized (gains) losses on derivatives and hedging activities, net (27,000) 17,809,000
Gains on sales of loans, net (249,878,000) (402,790,000)
Acquisition transaction costs, net 2,602,000 0
Other adjustments to net income, net 10,896,000 (31,210,000)
Changes in operating assets and liabilities:    
Increase in accrued interest receivable (372,454,000) (369,343,000)
Increase in non-marketable securities (992,000) (8,611,000)
(Increase) decrease in other interest-earning assets (528,000) 24,759,000
Increase in other assets (39,862,000) (96,253,000)
Decrease in income taxes payable, net (118,724,000) (232,124,000)
Decrease in accrued interest payable (2,535,000) (8,292,000)
Decrease in other liabilities (25,846,000) (8,399,000)
Total adjustments (468,386,000) (961,341,000)
Total net cash provided by (used in) operating activities 2,499,000 (179,933,000)
Investing activities    
Loans acquired and originated (2,857,411,000) (2,628,056,000)
Net proceeds from sales of loans held for investment 2,333,188,000 3,436,085,000
Proceeds from FFELP Loan claim payments 14,642,000 9,275,000
Net decrease in loans held for investment (other than loan sales) 2,007,215,000 1,892,800,000
Purchases of available-for-sale securities (753,129,000) (505,004,000)
Proceeds from sales and maturities of available-for-sale securities 741,059,000 582,090,000
Purchase of subsidiary, net of cash acquired (127,568,000) 0
Total net cash provided by investing activities 1,357,996,000 2,787,190,000
Financing activities    
Brokered deposit placement fee (3,790,000) (713,000)
Net decrease in certificates of deposit (1,131,940,000) (2,312,940,000)
Net increase in other deposits 353,506,000 816,013,000
Borrowings collateralized by loans in securitization trusts - issued 0 529,253,000
Borrowings collateralized by loans in securitization trusts - repaid (716,561,000) (534,282,000)
Issuance costs for unsecured debt offering (360,000) (325,000)
Fees paid on Secured Borrowing Facility (2,833,000) (2,846,000)
Common stock dividends paid (58,576,000) (20,170,000)
Preferred stock dividends paid (3,032,000) (2,393,000)
Common stock repurchased (545,498,000) (1,027,298,000)
Total net cash used in financing activities (2,109,084,000) (2,555,701,000)
Net increase (decrease) in cash, cash equivalents and restricted cash (748,589,000) 51,556,000
Cash, cash equivalents and restricted cash at beginning of period 4,545,344,000 4,609,709,000
Cash, cash equivalents and restricted cash at end of period 3,796,755,000 4,661,265,000
Cash disbursements made for:    
Interest 174,681,000 192,939,000
Income taxes paid 120,330,000 232,285,000
Income taxes refunded (2,023,000) (1,049,000)
Reconciliation of the Consolidated Statements of Cash Flows to the Consolidated Balance Sheets:    
Cash and cash equivalents 3,649,651,000 4,497,310,000
Restricted cash 147,104,000 163,955,000
Total cash, cash equivalents and restricted cash $ 3,796,755,000 $ 4,661,265,000